Versant Venture Capital VI, L.P. - 10%+ Owner at Monte Rosa Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Stock Symbol
GLUE on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Versant Venture Capital VI, L.P. - trading volume in the past year for Monte Rosa Therapeutics, Inc.

Holdings reported by Versant Venture Capital VI, L.P. for Monte Rosa Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 4.08M $38.4M $9.41 Oct 28, 2024 Direct
Common Stock 1.57M $14.8M $9.41 Oct 29, 2024 Indirect

Transactions reported by Versant Venture Capital VI, L.P. for Monte Rosa Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.